Mylan to Acquire Aspen's Thrombosis Business in Europe
Acquisition further complements and expands Mylan's complex injectables offering and presence in hospitals Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS™ HERTFORDSHIRE, England, a... Biopharmaceuticals, Acquisitions Mylan, Aspen Pharmacare (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2020 Category: Pharmaceuticals Source Type: news

CVT Incidence Three Times Higher Than Previously Reported CVT Incidence Three Times Higher Than Previously Reported
New data show the incidence of cerebral venous thrombosis is more than three times greater than previously reported, but whether the increase is real, or an artifact of better detection is unclear.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 4, 2020 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches
Great efforts are being made worldwide to identify the specific clinical characteristics of infected critically ill patients that mediate the associated pathogenesis, including vascular dysfunction, thrombosis, dysregulated inflammation, and respiratory complications. Recently, coronavirus disease 2019 has been closely related to sepsis, which suggests that most deaths in ICUs in infected patients are produced by viral sepsis. Understanding the physiopathology of the disease that lead to sepsis after severe acute respiratory syndrome coronavirus 2 infection is a current clinical need to improve intensive care-applied thera...
Source: Current Awareness Service for Health (CASH) - September 3, 2020 Category: Consumer Health News Source Type: news

Possible blood-clotting mechanism in COVID-19 found
(Uppsala University) Why so many COVID-19 patients get blood clots (thrombosis) remains uncertain. But scientists at Uppsala University and the University Hospital have now identified a mechanism they believe to be implicated. A particular protein triggers a part of our immune system that can boost the blood's tendency to coagulate and form clots. The study is now published in Thrombosis and Haemostasis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 2, 2020 Category: Infectious Diseases Source Type: news

UC study: Cancer, COVID-19 and blood clots
(University of Cincinnati) Shuchi Gulati, MD, assistant professor of medicine at the University of Cincinnati, is studying how treatments for patients with cancer and COVID-19 could cause other health complications, namely blood clots. She recently received a $25,000 grant from the North American Thrombosis Forum to help her investigate this problem. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2020 Category: Cancer & Oncology Source Type: news

Journal of Spinal Cord Medicine names Dr. Beverly Hon winner of Ernest Bors Award
(Kessler Foundation) The Journal of Spinal Cord Medicine& the Academy of Spinal Cord Injury Professionals announce that Beverly Hon, MD, is the recipient of this year's Ernest Bors, MD Award for Scientific Development. Dr. Hon is primary author of 'Duplex ultrasound surveillance for deep vein thrombosis after acute traumatic spinal cord injury at rehabilitation admission.' Because of the risk for complications following distal DVT, screening on admission for rehabilitation may be advisable to identify at-risk patients in need of followup. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 31, 2020 Category: International Medicine & Public Health Source Type: news

Hospitalized COVID-19 Patients and Venous Thromboembolism Hospitalized COVID-19 Patients and Venous Thromboembolism
Early reports indicate that a very high proportion of critically ill patients hospitalized with COVID-19 will experience venous thromboembolism, particularly pulmonary embolism.Circulation (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 28, 2020 Category: Radiology Tags: Infectious Diseases Journal Article Source Type: news

What Is cerebral venous thrombosis? Upstate study finds blood clot condition on the rise
Study author, Upstate's Dr. Fadar Oliver Otite, found that the number of cases of CVT in the United States is three times higher than previously reported. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - August 26, 2020 Category: Universities & Medical Training Tags: News Source Type: news

Blacks Have Higher Incidence of Cerebral Venous Thrombosis
WEDNESDAY, Aug. 26, 2020 -- Black Americans have a higher incidence of cerebral venous thrombosis (CVT) compared with other races, according to a study published online Aug. 26 in Neurology. Fadar Oliver Otite, M.D., from the State University of New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 26, 2020 Category: Pharmaceuticals Source Type: news

Rare'Brain Vein' Strokes Are on the Rise
WEDNESDAY, Aug. 26, 2020 -- Most strokes strike when an artery in the brain suddenly becomes blocked, but new research shows a rarer cause of strokes is becoming more common. It's called cerebral venous thrombosis (CVT), and it happens when a vein... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 26, 2020 Category: General Medicine Source Type: news

DVT in Rheumatoid Arthritis Presenting as a Calf Strain DVT in Rheumatoid Arthritis Presenting as a Calf Strain
This case report underscores the need to be aware of deep vein thrombosis as a potential risk in rheumatoid arthritis, even in young, physically fit individuals.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Subclinical Thrombosis of Bioprosthetic Aortic Valves Subclinical Thrombosis of Bioprosthetic Aortic Valves
While TAVR has been shown to improve quality of life and prolong survival, the clinical significance of subclinical bioprosthetic valve thrombosis, as detected by advanced imaging, remains uncertain.Journal of the American College of Cardiology (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 21, 2020 Category: Radiology Tags: Cardiology Journal Article Source Type: news

Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis
In this study, we used three thrombotic mice models to confirm the antithrombotic property of embelin. By combining the anti-inflammatory and the antithrombotic properties, we proposed embelin as a potent therapeutic agent for sepsis-induced DIC, which involves both inflammation and thrombosis. In a lipopolysaccharides-induced septic mice model, embelin not only significantly ameliorated the inflammation levels, but also effectively reduced the pulmonary hemorrhages and the micro-thrombi formations in lung. In contrast, low-molecular-weight-heparin, an anticoagulant, only moderately ameliorated the pulmonary hemorrhages an...
Source: Current Awareness Service for Health (CASH) - August 5, 2020 Category: Consumer Health News Source Type: news

Obesity in Young Adulthood Tied to Later Venous Thromboembolism
Men with higher BMI in young adulthood showed an incrementally increasing risk for VTE (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 29, 2020 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Internal Medicine, Emergency Medicine, Neurology, Oncology, Pulmonology, Journal, Source Type: news

Obesity in Young Adulthood Tied to Later Venous Thromboembolism
WEDNESDAY, July 29, 2020 -- Men who are obese or severely obese in young adulthood have an increased risk for venous thromboembolism (VTE) later in life, according to a study published in the June issue of the Journal of Internal Medicine. K. Glise... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Complement Inhibition and COVID-19-Related Systemic Thrombosis Complement Inhibition and COVID-19-Related Systemic Thrombosis
Emerging data suggests that complement inhibition may be a promising treatment for severe COVID-19 by reducing the innate immune-mediated consequences of severe coronavirus infection.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2020 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

University of Edinburgh seeks - Research Fellow
The Usher Institute at the University of Edinburgh is seeking a highly skilled and motivated epidemiologist/research fellow to work in the field of vascular disease, including both the diagnosis and treatment of peripheral vascular diseases and the development of vascular complications of type 2 diabetes. The primary role will be to undertake a series of high quality systematic reviews on the prevention, diagnosis and treatment of vascular diseases, including abdominal aortic aneurysm, venous thromboembolism and peripheral arterial disease, within the core programme of work which constitutes the CSO funded research project...
Source: Cochrane News and Events - July 22, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Discovery of novel autoantibody that is a major risk factor for recurrent pregnancy loss
(Kobe University) A Kobe University led study has revealed for the first time in the world the high frequency of a novel autoantibody in women suffering from recurrent pregnancy loss. It is expected that these results will contribute towards the illumination of the underlying mechanisms behind this disorder, thrombosis, and pregnancy complications such as hypertensive disorders; leading to the development of new treatment methods. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2020 Category: International Medicine & Public Health Source Type: news

What Are Some Pediatric Oncological Emergencies?
Discussion Pediatric cancers in the US number about 12,000 per year. After injury, it is the second leading cause of death in children and adolescents. Cancer presentations vary widely, but often begin with non-specific symptoms that continue or progress depending on the location and tumor type. Patients can present with oncological emergencies especially if there are mechanical obstruction such as superior vena cava syndrome or cerebral herniation. More commonly are infections due to immunosuppression. Cancer treatment also causes its own myriad of problems that clinicians need to be aware of to diagnosis and treat, but a...
Source: PediatricEducation.org - July 20, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Electrical weapons, hematocytes, and ischemic cardiovascular accidents - Kroll MW, Witte KK, Kunz SN, Luceri RM, Criscione JC.
BACKGROUND: There have been case reports following the use of a conducted electrical weapon (CEW) suggesting that these devices might affect coagulation or thrombosis in at-risk individuals. The aim of this manuscript therefore is firstly to explore this h... (Source: SafetyLit)
Source: SafetyLit - July 16, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

What Causes a Thrombus
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 15, 2020 Category: General Medicine Source Type: news

Coronavirus: Blood clotting present in every patient who dies
Professor Graham Cooke, of Imperial College London, said post mortems 'showed very clearly' that every patient had some form of thrombosis - the formation of a blood clot in a vessel. (Source: the Mail online | Health)
Source: the Mail online | Health - July 14, 2020 Category: Consumer Health News Source Type: news

What are the risk factors and effectiveness of prophylaxis for venous thromboembolism in COVID-19 patients?, CEBM
This study identified a paucity of evidence for both the risks factors of VTE and the effectiveness of prophylactic strategies to prevent VTE in COVID-19 patients. Potential risk factors which were identified for thrombolytic events include older age and higher levels of D-dimer, though the actual threshold for a high level D-dimer varied between studies. Commonly encountered prophylactic strategies which were; low molecular weight heparin (LMWH) or unfractionned heparin, nadroparin and enoxaparin. A number of studies found that despite prophylaxis there was still a high incidence of thrombolytic complications in COVID-1...
Source: Current Awareness Service for Health (CASH) - July 13, 2020 Category: Consumer Health News Source Type: news

New data from phase IIIb study reinforces safety profile of Roche ’s Hemlibra in people with haemophilia A
Basel, 13 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from the second interim analysis of the phase IIIb STASEY study, which reinforce the safety profile of Hemlibra ® (emicizumab) characterised in the phase III HAVEN clinical programme.1,2,3 In the STASEY study, Hemlibra was effective with no new safety signals identified in adults and adolescents with haemophilia A with factor VIII inhibitors, which was consistent with previous safety observations.1 Further new interim data suggest that people on Hemlibra may be able to undergo certain minor surgeries without additional preventative (prophy...
Source: Roche Investor Update - July 13, 2020 Category: Pharmaceuticals Source Type: news

International Society on Thrombosis and Haemostasis and the American Heart Association Release scientific statement outlining venous thromboembolism research priorities
(American Heart Association) The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) have released a joint scientific statement titled, " Venous Thromboembolism Research Priorities, " identifying five top priorities for research on venous thromboembolism (VTE), published today in the ISTH journal Research and Practice in Thrombosis and Haemostasis (RPTH) and Circulation, the flagship journal of the American Heart Association. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2020 Category: International Medicine & Public Health Source Type: news

Late coronary stent thrombosis in patient with COVID-19
(JAMA Network) This case report describes a patient with COVID-19 who developed late drug-eluting stent thrombosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 8, 2020 Category: Infectious Diseases Source Type: news

Acute myocardial injury caused by black widow spider (Latrodectus) bite - Gogos C, Sachpekidis V, Davora F, Bompotis G.
A 40-year-old male presented to the emergency department due to multiple black widow spider bites mainly located in the abdominal and lumbar area (Figure 1). Patient's medical history included deep venous thrombosis 3  years ago now on treatment with aspi... (Source: SafetyLit)
Source: SafetyLit - July 6, 2020 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis
OBJECTIVE: To evaluate the impact of early disseminated intravascular coagulation (DIC) on illness severity in children using a database of ED encounters for children with suspected sepsis, in view of similar associations in adults. STUDY DESIGN: Laboratory and clinical data were extracted from a registry of Emergency Department (ED) encounters of children with suspected sepsis between April 01, 2012 and June 26, 2017. International Society of Thrombosis and Hemostasis DIC scores were calculated from laboratory values obtained within 24 hours of ED admission. Univariate logistic regression, multivariable logistic regressio...
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
Conclusion(s): New evidence on thromboembolism in COVID-19 does not warrant a change in current guidance on thromboprophylaxis among hospitalized patients. Prospective trials of antithrombotic treatment strategies among patients with COVID-19 are urgently needed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 1, 2020 Category: Consumer Health News Source Type: news

Rivaroxaban good choice for prevention of venous thromboembolism
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2020 Category: Drugs & Pharmacology Source Type: news

Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia A
Basel, 29 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from its haemophilia A clinical programme will be presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Congress on 12-14 July 2020. Data will include updated safety results from the phase IIIb STASEY study of Hemlibra ® (emicizumab) and new results from the phase III HAVEN 5 study of Hemlibra. Data will also include insights into the impact of living with haemophilia A. Spark Therapeutics (a member of the Roche Group) will also present data from the initial dose cohorts of its phase I/II SPK-8011 gene ther...
Source: Roche Media News - June 29, 2020 Category: Pharmaceuticals Source Type: news

Roche announces new data at the ISTH 2020 Congress, demonstrating ongoing commitment to advancing care for people with haemophilia A
Basel, 29 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from its haemophilia A clinical programme will be presented at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Congress on 12-14 July 2020. Data will include updated safety results from the phase IIIb STASEY study of Hemlibra ® (emicizumab) and new results from the phase III HAVEN 5 study of Hemlibra. Data will also include insights into the impact of living with haemophilia A. Spark Therapeutics (a member of the Roche Group) will also present data from the initial dose cohorts of its phase I/II SPK-8011 gene ther...
Source: Roche Investor Update - June 29, 2020 Category: Pharmaceuticals Source Type: news

Incidence of VTE, Major Bleeding High in Primary CNS Lymphoma
MONDAY, June 29, 2020 -- The incidence of venous thromboembolism (VTE) and major bleeding is high among patients with primary central nervous system lymphoma (PCNSL), according to a study published online June 23 in Leukemia& Lymphoma. Anjlee... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2020 Category: Pharmaceuticals Source Type: news

Clinical guide for the prevention, detection and management of thromboembolic disease in patients with COVID-19, RCP
Several studies have demonstrated coagulation changes in patients with COVID-19, especially inthose with severe disease, and this is associated with a worse prognosis. Emerging data, alongside recent clinical experience, have suggested a high prevalence of venous thromboembolism (VTE) in patients with COVID-19. This document provides guidance on the prevention, diagnosis and management of VTE in patients with COVID-19 who are seen in hospital. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 23, 2020 Category: Consumer Health News Source Type: news

Incidence of antithrombin deficiency and anti-cardiolipin antibodies after severe traumatic brain injury: a prospective cohort study - Kalgudi S, Ho KM.
BACKGROUND: Animal studies suggested that cerebral mitochondrial cardiolipin phospholipids were released after severe traumatic brain injury (TBI), contributing to the pathogenesis of thromboembolism. OBJECTIVES: To determine the incidence of anti-... (Source: SafetyLit)
Source: SafetyLit - June 22, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets
Rivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and treatment of pulmonary embolism (PE). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 22, 2020 Category: Pharmaceuticals Source Type: news

Thrombosis in COVID-19: What We Know and How to Treat Thrombosis in COVID-19: What We Know and How to Treat
Hematologist Mary Cushman discusses arterial and venous thrombosis issues with SARS-CoV-2 and the role of anticoagulation.theheart.org on Medscape (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 18, 2020 Category: Intensive Care Tags: Cardiology Expert Interview Source Type: news

Case Series Hints at Excess Stent Thrombosis During COVID-19 Case Series Hints at Excess Stent Thrombosis During COVID-19
Stent thrombosis rates may be up during the pandemic, a new case series suggests. The finding needs verification, but signals the need for greater vigilance, researchers say.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 9, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

TNF Inhibitors Cut Odds of VTE in RA Patients TNF Inhibitors Cut Odds of VTE in RA Patients
For patients with rheumatoid arthritis (RA), a TNF inhibitor might help reduce risk for venous thromboembolism (VTE), new research from a large dataset shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2020 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Postpartum CVT Misdiagnosed As Postdural Puncture Headache Postpartum CVT Misdiagnosed As Postdural Puncture Headache
This case highlights the need to be aware of the risk of postpartum cerebral venous thrombosis, a potentially fatal complication of the postpartum period.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 8, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Medtronic Expands Indications for the Resolute Onyx DES in Europe
Medtronic has scored CE mark for a unique indication for the Resolute Onyx drug-eluting stent. The Dublin-based company said the approval was for a DAPT indication for high bleeding risk (HBR) patients. The firm said for HBR patients whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and anti-clotting medication), this new, indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention (PCI) with Resolute Onyx. The indication is based on results from the Onyx ONE Global Study, a prospective, randomized, one-month DAPT...
Source: MDDI - June 8, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Cardiovascular Source Type: news

Coronavirus (COVID-19) infection and pregnancy, RCOG (updated 4th June 2020)
This is guidance for healthcare professionals on coronavirus (COVID-19) infection in pregnancy, published by the RCOG, Royal College of Midwives, Royal College of Paediatrics and Child Health, Public Health England and Public Health Scotland. This is version 10 (published 4th June) and has been updated to condense the content and ensure the evidence and rationale for advice is explicit. Also contains: new content on labour and birth for women who asymptomatic of COVID-19 updates to advice for women with clinical deterioration reference to the new testing frameworks further advice regarding prevention of venous-thro...
Source: Current Awareness Service for Health (CASH) - June 8, 2020 Category: Consumer Health News Source Type: news

What Causes Free Peritoneal Fluid?
Discussion Peritoneal fluid is normal. It decreases the friction of the peritoneum covering abdominal and pelvic organs and helps to protect them and allow their movement. A normal amount of peritoneal fluid is expected on radiological evaluation. Increased peritoneal fluid is a continuum and is concerning as a wide variety of pathological causes are associated with it such as abdominal trauma and appendicitis. At the far end of the scale is ascites that is the accumulation of free fluid more than 25 ml. It is usually associated with abdominal distension but fluid must accumulate before distension can occur and therefore i...
Source: PediatricEducation.org - June 8, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Thrombosis in COVID-19: clinical outcomes, biochemical and pathological changes, and treatments, CEBM
Reports that COVID-19 is associated with venous and arterial thrombosis and pulmonary embolism and increased rates of thrombosis in cannulae and extracorporeal circuits for renal replacement or membrane oxygenation, have drawn attention to the coagulant effects of the disease. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

Is carbon monoxide poisoning a risk factor or a bystander of deep venous thrombosis? - Xu Y, Li W.
In a recent issue of Annals, Cho et al investigated the risk of deep venous thrombosis after carbon monoxide poisoning. They found that it was significantly increased by 90 days after carbon monoxide poisoning. The authors used a cohort crossover design in... (Source: SafetyLit)
Source: SafetyLit - June 2, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

High Rates of DVT Seen in Critically Ill COVID-19 Patients
TUESDAY, June 2, 2020 -- Despite anticoagulant prophylaxis, many intensive care unit (ICU) patients with severe COVID-19-related pneumonia develop deep vein thrombosis, according to a research letter published online May 29 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 2, 2020 Category: Pharmaceuticals Source Type: news

High number of patients with severe COVID-19 develop deep vein thrombosis
A high number of patients with severe COVID-19 develop deep vein thrombosis, or dangerous blood clots that can migrate to the lungs, a study published Friday by JAMA Network Open has found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 29, 2020 Category: Consumer Health News Source Type: news

Venous thrombosis among critically ill patients with COVID-19
(JAMA Network) A   systematic assessment of deep vein thrombosis among patients in an intensive care unit in France with severe COVID-19 is reported in this case series. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 29, 2020 Category: Infectious Diseases Source Type: news

Autopsy Data Show Extensive Lung Damage From COVID-19 Autopsy Data Show Extensive Lung Damage From COVID-19
A small autopsy study shows severe lung damage from COVID-19, but is it different than that seen in severe influenza? A thrombosis expert suggests the findings are not a surprise.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 26, 2020 Category: Allergy & Immunology Tags: Cardiology News Source Type: news

Covid-19 and thrombosis: what do we know about the risks and treatment?, BMJ
This BMJ news report discusses the observed increased risk of thrombosis in patients with Covid-19. One expert notes that there are still high rates of DVT, PE and immunothrombosis in Covid-19 patients despite prophylaxis, with some arguing that bigger doses should be given. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 26, 2020 Category: Consumer Health News Source Type: news